Skip to main content
. 2010 Nov 19;300(2):L225–L231. doi: 10.1152/ajplung.00264.2010

Fig. 6.

Fig. 6.

TNFR1 deficiency protects against doxorubicin-induced diaphragm dysfunction. A: body weight over 3 days following doxorubicin administration. Specific force (B) and relative force (C) measured 72 h following injection. Data are means ± SE; n = 8 (vehicle) or 7 (doxorubicin); for A and C, P < 0.01 for overall difference by repeated-measures ANOVA; *P < 0.01 by Bonferroni test.